CardioScale Overview
CardioScale provides on-site deterioration prediction for trauma victims. The companys solution helps save lives by enabling better triage and improved treatment prioritization decisions via its proprietary algorithm and portable cuff monitor, DTR8. CardioScale holds a worldwide patent for early shock diagnostics with a ready-to-use field monitor that measures all vital signs in addition to a proprietary cardiovascular reserve index (CVRI) to detect shock and preshock deterioration. The DTR8 measurement procedure is similar to that of a blood pressure test and provides comprehensive results in under 60 seconds. Measured indices are then calculated automatically using patented CVRI technology, and the results are transmitted wirelessly to a handheld device for review as well as displayed on the device itself. This numeric data can be used to evaluate the patients current condition as well as to provide a baseline for follow-up tests.
Latest News
Unknown
Cardiovascular Reserve Index (CVRI) calculator receives a CE Mark approval
The Cardiovascular Reserve Index (CVRI) calculator has received CE Marking approval, allowing its clinical use in the European Union and other countries that recognize CE Marking. CVRI is a multi-vital sign index that detects hemodynamic changes in patients. It is intended for use in apparently stable patients who are being monitored and can enable pattern detection and dynamic monitoring. The CVRI Calculator complies with the directive 93/42/EEC and is classified as class IIa.
growth-positive
An Israeli development will save lives in mass casualty events
Israeli medtech startup CardioScale has developed a portable sensor that can quickly check vital cardiovascular data and determine the urgency of treatment for each patient in emergency medical situations. The device measures breathing, pulse, blood pressure, saturation, CO2, and the patent-protected CVRI-CardioVascular Reserve Index. CardioScale won the Combating Terrorism Technology Startup Challenge and received a $100,000 development grant from the US Department of Defense. The company plans to supply the Israeli army with the first batch of 40 devices and later provide devices to the US Department of Defense. CardioScale aims to develop a device that can handle multi-casualty incidents worldwide and is also exploring the possibility of allowing individual patients to perform the test at home. The Israel Export Institute supports CardioScale and other Israeli medical technology companies in creating business opportunities globally.
Customers
growth-positive
Winners Announced in Counter-Terrorism Startup Competition
CardioScale Ltd. and Colugo Systems Ltd., both early-stage startups based in Israel, won top honors at the international competition sponsored by the U.S. and Israeli governments. CardioScale Ltd. won first place and $100,000 prize with a device that promises to help monitor the vitals of survivors of terrorist attacks and mass casualty events. Second place, and a $10,000 check, went to Colugo Systems Ltd., which is developing a hybrid drone that combines the features of a quadrotor and a fixed-wing unmanned aerial vehicle. Both companies are early-stage startups based in Israel.
Customers
growth-positive
http://www.israeldefense.co.il/en/node/34354
Twenty startups have been chosen to compete for $220,000 in prizes at the 2018 Combating Terrorism Technology Startup Challenge (CTTSC3). The contest, organized by the US Department of Defense, aims to identify startups with technologies that can help defeat terrorism. The number of entries for the challenge has doubled since the last competition in 2016, with a broad variety of startups participating across different technology and application domains. Major trends this year include technologies for analyzing social media and online behavior, as well as the growth of drone-related technologies. The contest provides exposure to potential funding bodies, customers, investors, and partners worldwide.
PartnersInvestment
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $100K |
| Last funding | $100K |
| Stage | Pre-Funding |
| Rounds | 1 |
| Investors | 0 |
Team Members
2
Employees: 1-10
Web & Social Links
| Website | www.cardioscale.com |
Locations
Yam HaMelach Street 45, Ganei Tikva, Israel
Photos & Videos
2 item(s)
CardioScale Business
Business models
B2B, B2G
Product stage
Clinical Trial
Employees
1-10
Sector
Health Tech & Life SciencesMedical DevicesMedical MonitorsDigital HealthcarePatient Remote MonitoringTarget Customer
Healthcare & Life SciencesHealthcarePatientsProvidersMedical Devices IndustryMedical EquipmentDefense, Safety & SecurityNational SecurityMilitaryCivilCore Technology
SensingTags (12)
heart-failuremilitarydiagnosticsearly-detectionnon-invasivedigital-healthcarewireless-communicationhospitalsmedical-devicescritical-caredata-analyticsremote-monitoringGeographic Markets
IsraelCardioScale Financials
$100K
Total funding
—
Capital raised
$100K
Last funding
Pre-Funding
Funding stage
1
Total rounds
0
Investors
Non-Equity Funding
GrantEvent
Jul 2018
$100K
Combating Terrorism Technology Startup Challenge (CTTSC3)
CardioScale Lifecycle
All Events
GrantEvent
Jul 2018
$100K
Combating Terrorism Technology Startup Challenge (CTTSC3)
CardioScale News
4 articles
Unknown
Cardiovascular Reserve Index (CVRI) calculator receives a CE Mark approval
The Cardiovascular Reserve Index (CVRI) calculator has received CE Marking approval, allowing its clinical use in the European Union and other countries that recognize CE Marking. CVRI is a multi-vital sign index that detects hemodynamic changes in patients. It is intended for use in apparently stable patients who are being monitored and can enable pattern detection and dynamic monitoring. The CVRI Calculator complies with the directive 93/42/EEC and is classified as class IIa.
growth-positive
An Israeli development will save lives in mass casualty events
Israeli medtech startup CardioScale has developed a portable sensor that can quickly check vital cardiovascular data and determine the urgency of treatment for each patient in emergency medical situations. The device measures breathing, pulse, blood pressure, saturation, CO2, and the patent-protected CVRI-CardioVascular Reserve Index. CardioScale won the Combating Terrorism Technology Startup Challenge and received a $100,000 development grant from the US Department of Defense. The company plans to supply the Israeli army with the first batch of 40 devices and later provide devices to the US Department of Defense. CardioScale aims to develop a device that can handle multi-casualty incidents worldwide and is also exploring the possibility of allowing individual patients to perform the test at home. The Israel Export Institute supports CardioScale and other Israeli medical technology companies in creating business opportunities globally.
Customers
growth-positive
Winners Announced in Counter-Terrorism Startup Competition
CardioScale Ltd. and Colugo Systems Ltd., both early-stage startups based in Israel, won top honors at the international competition sponsored by the U.S. and Israeli governments. CardioScale Ltd. won first place and $100,000 prize with a device that promises to help monitor the vitals of survivors of terrorist attacks and mass casualty events. Second place, and a $10,000 check, went to Colugo Systems Ltd., which is developing a hybrid drone that combines the features of a quadrotor and a fixed-wing unmanned aerial vehicle. Both companies are early-stage startups based in Israel.
Customers
growth-positive
http://www.israeldefense.co.il/en/node/34354
Twenty startups have been chosen to compete for $220,000 in prizes at the 2018 Combating Terrorism Technology Startup Challenge (CTTSC3). The contest, organized by the US Department of Defense, aims to identify startups with technologies that can help defeat terrorism. The number of entries for the challenge has doubled since the last competition in 2016, with a broad variety of startups participating across different technology and application domains. Major trends this year include technologies for analyzing social media and online behavior, as well as the growth of drone-related technologies. The contest provides exposure to potential funding bodies, customers, investors, and partners worldwide.
PartnersInvestment
CardioScale Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 1 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 16 classification IDs that could be used for matching.
CardioScale Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 99/100 |
| Missing | funding rounds, markets |
| BI Verification | Jenny Sotnik-Talisman |
| Registrar ID | 514741701 |
| Crunchbase | cardioscale |
| Phone | +97235343736 |
| Creator | Sharon Shapira |
| Creator email | shapira.sharon2@gmail.com |
| Last updater | Matan Eblagon |
| Updater email | matane@sncentral.org |
| Last update | 2023-08-21T00:00:00.000Z |
| Created | 2015-03-29T00:00:00.000Z |
| Claimed | Yes |